A case of fulminant type 1 diabetes after erythema multiforme.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R.
Lancet. 2016 Nov 5;388(10057):2254-2263. doi: 10.1016/S0140-6736(16)31535-5. Epub 2016 Sep 12.
Cutaneous Manifestations of Diabetes Mellitus: A Review.
Lima AL, Illing T, Schliemann S, Elsner P.
Am J Clin Dermatol. 2017 Aug;18(4):541-553. doi: 10.1007/s40257-017-0275-z.
Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review.
Zhang X, Huang D, Lou D, Si X, Mao J.
BMC Endocr Disord. 2024 Sep 2;24(1):172. doi: 10.1186/s12902-024-01683-5.
Cutaneous adverse events in a randomized controlled trial of flash glucose monitoring among youth with type 1 diabetes mellitus.
Marsters BL, Boucher SE, Galland BC, Wiltshire EJ, de Bock MI, Tomlinson PA, Rayns J, MacKenzie KE, Chan H, Wheeler BJ.
Pediatr Diabetes. 2020 Dec;21(8):1516-1524. doi: 10.1111/pedi.13121. Epub 2020 Oct 4.
Efficacy and safety of a rosehip seed oil extract in the prevention and treatment of skin lesions in the hands of patients with type 1 diabetes mellitus caused by finger prick blood glucose monitoring; a randomized, open-label, controlled clinical trial.
Aguirre-Romero AB, Galeano-Valle F, Conde-Montero E, Velázquez-Tarjuelo D, de-la-Cueva-Dobao P.
Endocrinol Diabetes Nutr (Engl Ed). 2020 Mar;67(3):186-193. doi: 10.1016/j.endinu.2019.04.008. Epub 2019 Jun 21.
"Out of the box" solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray.
Paret M, Barash G, Rachmiel M.
Acta Diabetol. 2020 Apr;57(4):419-424. doi: 10.1007/s00592-019-01446-y. Epub 2019 Nov 8.
A case of fulminant type 1 diabetes after erythema multiforme.
Ma Z, Zhang W.
Diabetes Res Clin Pract. 2016 Oct;120:182-3. doi: 10.1016/j.diabres.2016.08.003. Epub 2016 Aug 19.
Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.
Nikolic T, Zwaginga JJ, Uitbeijerse BS, Woittiez NJ, de Koning EJ, Aanstoot HJ, Roep BO.
Lancet Diabetes Endocrinol. 2020 Jun;8(6):470-472. doi: 10.1016/S2213-8587(20)30104-2. Epub 2020 May 5.
Rituximab Therapy for Insulin Allergy in Type-1 Diabetes Mellitus.
DeClue CE, Phillips EJ, Prieto-Granada C, Bao S.
AACE Clin Case Rep. 2024 Apr 16;10(4):140-143. doi: 10.1016/j.aace.2024.04.002. eCollection 2024 Jul-Aug.
Cutaneous mucormycosis as a presenting feature of type 1 diabetes in a boy - case report and review of the literature.
Jevalikar G, Sudhanshu S, Mahendru S, Sarma S, Farooqui KJ, Mithal A.
J Pediatr Endocrinol Metab. 2018 Jun 27;31(6):689-692. doi: 10.1515/jpem-2017-0404.
